Hospital-acquired infections (HAI) cause 99,000 deaths a year in US hospitals alone.
Annual financial losses due to HAI are estimated by the World Health Organization at approximately $6.5 billion in the US and €7 billion in Europe, including direct costs only.
Treating a patient with HAI in the USA can cost several thousand dollars. In Europe, it ranges from €4,200 to €13,030.
Antimicrobial resistance is an increasingly serious threat to global public health. Coordinated action is required to minimize the emergence and spread of antimicrobial resistance.
In healthcare settings, infectious microorganisms may survive and proliferate in a number of places for extended periods of time.
Current infection control in hospital environments addresses sterilization of surfaces, infection control in the operating room and hand hygiene.
Reducing the number of infections by controlling transmission routes:
• Antimicrobial workwear & textiles by Medanta Oy; www.medantaglobal.com
• High-performance air purification by Genano Ltd; and www.genano.com
• Hygienic vacuum transfer for linen and waste by Ecosir Group. www.ecosir.com